Merger Completed
Kincell Bio and Cellipont Bioservices merger
Announced Sep 2026 (approx.)
Advisers
Cellipont Bioservices
Target
Not disclosed
Acquirer
Not disclosed
Other advisers
- Financial adviser
- Target
- Cellipont Bioservices
- Target based in
- United States
- Completed
- Sep 2026
- Sector
- Pharma Services
- Tags
- Pharma Services, Cell Therapy, Life Sciences
In the league tables
Similar deals
- Webster Equity Partners acquisition of Lifecore Biomedical Sep 2026 · US$664m · Pharma Services
- Everest Clinical Research acquisition of Firma Data Services Sep 2026 · Clinical Trial Services
- VION acquisition of Prolytix Sep 2026 · Pharma Services
- McKesson acquisition of Precision Medicine Group Aug 2026 · US$2.3bn · Clinical Trial Services
- NueCell Bio acquisition of assets, business operations and customer relationships Aug 2026 · Pharma Services
